doxorubicin hydrochloride
- Product NDC
- 46708-810
- 11-digit product format
- 467080810
- Labeler code
- 46708
- Product ID
- 46708-810_f8e001f5-441c-47cd-86f6-5d5e3de16bc0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- doxorubicin hydrochloride
- Dosage form
- INJECTION, SUSPENSION, LIPOSOMAL
- Route
- INTRAVENOUS
- Labeler
- Alembic Pharmaceuticals Limited
- Application
- ANDA219199
- Marketing category
- ANDA
- Marketing start
- 2025-06-27
- Substance
- DOXORUBICIN HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 82F2G7BL4E | DOXORUBICIN HYDROCHLORIDE | 25316-40-9 | DOXORUBICIN HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 46708-810-10 | 46708081010 | 1 VIAL, SINGLE-DOSE in 1 CARTON (46708-810-10) / 10 mL in 1 VIAL, SINGLE-DOSE | 2025-06-27 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| doxorubicin hydrochloride | Alembic Pharmaceuticals Limited | 2025-07-01 | Human Prescription Drug Label | 1 |